Capricor Therapeutics (CAPR) FCF Margin Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) FCF Margin Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3,679.00 |
| Sep 30, 2024 | -36,865.00 |
| Jun 30, 2024 | -6,707.00 |
| Mar 31, 2024 | -14,809.00 |
| Dec 31, 2023 | 69,081.00 |
| Sep 30, 2023 | 24,574.00 |
| Jun 30, 2021 | 188,979.00 |
| Mar 31, 2021 | -759,145.00 |
| Dec 31, 2020 | -633,881.00 |
| Sep 30, 2020 | -1.74 Mn |
| Jun 30, 2020 | -382,673.00 |
| Mar 31, 2020 | 4,147.00 |
| Dec 31, 2019 | -22,421.00 |
| Sep 30, 2019 | 26,408.00 |
| Jun 30, 2019 | 48,073.00 |
| Mar 31, 2019 | 20,343.00 |
| Dec 31, 2018 | -1,890.00 |
| Sep 30, 2018 | -40,305.00 |
| Jun 30, 2018 | 27,217.00 |
| Mar 31, 2018 | -36,968.00 |